Ming Hsieh Increases Stake in Fulgent Genetics to 32.26% Following RSU Vesting

Ming Hsieh, the Chief Executive Officer and Chairperson of Fulgent Genetics, Inc., filed an amendment to Schedule 13D on May 27, 2026, reporting a beneficial ownership of 8,872,539 shares of Common Stock. This represents 32.26% of the company's 27,493,435 outstanding shares as of May 22, 2026. The increase in holdings since the previous filing resulted from the vesting of 5,496 Restricted Stock Units (RSUs) on May 26, 2026, with 2,949 shares withheld for taxes. The reporting person holds 8,650,723 shares with sole voting and dispositive power, including 7,895,115 shares held by The Ming Hsieh Trust and 746,423 shares held directly. Additionally, Hsieh shares power over 221,816 shares, primarily through the Dynasty Trust. Notably, a significant portion of the Trust's holdings is encumbered: 1,000,000 shares are pledged under a pre-paid forward arrangement, and 5,760,733 shares serve as collateral for a credit facility with Charles Schwab. Hsieh maintains these positions for general investment purposes.